Author

N. O. Stevers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Yamamichi· 2 shared C. Hong· 2 shared D. W. Kwok· 2 shared H. Okada· 2 shared J. F. Costello· 2 shared J. J. Phillips· 2 shared L. H. Chen· 2 shared M. Gallus· 2 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Yamamichi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

T. Nejo, L. Wang, K. K. Leung, A. Wang, S. Lakshmanachetty, M. Gallus, D. W. Kwok, C. Hong, L. H. Chen, D. A. Carrera, M. Y. Zhang, N. O. Stevers, G. C. Maldonado, A. Yamamichi, P. Watchmaker, , H. Okada

The paper identifies tumor-specific alternative splicing events in glioma that could generate cell-surface antigens but finds significant spatiotemporal heterogeneity and lack of proteomic evidence.

bioRxiv · Oct 26, 2023Cancer Biology

Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens

D. W. Kwok, N. O. Stevers, T. Nejo, L. H. Chen, I. Etxeberria, J. Jung, K. Okada, M. Colton Cove, S. Lakshmanachetty, M. Gallus, A. Barpanda, C. Hong, G. K. L. Chan, S. H. Wu, E. Ramos, , H. Okada

The paper identifies tumor-wide splicing aberrations that generate public neoantigens, enabling T-cell-based immunotherapies targeting intratumoral heterogeneity.

bioRxiv · Oct 19, 2023 · PreprintCancer Biology